M&A Rumors Turn Into Reality – The Special Situations Report Episode #33

Episode Summary

Executive Summary: Episode 33 of the Special Situations Report covered a busy week of event-driven activity: escalating bids for Dallas News, completed acquisitions of Soho House, Tegna, Guess, and Dayforce, major buybacks from several companies, a notable insider buy in Madrigal Pharmaceuticals, and leadership changes at Palo Alto Networks and Martin Transport. The hosts emphasized how takeover rumors, strategic alternatives, and capital returns continue to create opportunities and cautionary signals across sectors.

Main Topics: Escalating bidding war for Dallas News (Priority: 5/5): Hearst and MNG continued to compete for Dallas News, with MNG raising its offer to $18.50 per share despite a poison pill and strong opposition from former CEO Robert Decherd, who controls most voting power through Class B shares. Completed and rumored take-private transactions (Priority: 5/5): The episode reviewed several deal processes that matured into announced transactions, including Soho House, Guess, and Dayforce, highlighting how higher bids and competitive tension ultimately drove final prices above initial offers. Media consolidation and broadcasting valuations (Priority: 4/5): Tegna’s $22-per-share acquisition by Nexstar was framed as part of broader consolidation in local broadcasting, helped by a more permissive regulatory backdrop and the cyclical nature of election-driven advertising revenues. Share repurchases and capital return (Priority: 4/5): Multiple companies announced large buybacks, including Pediatrix Medical Group, Old Republic, Sprouts Farmers Market, and DaVita, signaling confidence in cash generation and/or undervaluation. Biotech insider buying and M&A in cash-rich biotech (Priority: 4/5): Madrigal Pharmaceuticals drew attention from a major insider purchase by chairman Julian Baker, while Zoma Royalty’s acquisition of Mural Oncology showed continued appetite for cash-rich or underappreciated biotech names. Technology and identity/security consolidation (Priority: 3/5): Palo Alto Networks’ acquisition of CyberArk and the departure of founder/CTO Nir Zuk raised governance and strategic questions, while management framed the deal as a way to “solve” identity security at scale. Management turnover and boomerang CEOs (Priority: 3/5): Martin Transport’s CEO transition back to former CEO Randolph Martin was presented as a potentially positive reset after a difficult operating period and as another example of a return-to-founder-style leadership change.

Key Arguments: Dallas News remains highly uncertain because voting control is concentrated with Robert Decherd’s family, making deal approval dependent on a holder openly opposed to the MNG bid. The market’s pricing of Dallas News below the existing offer suggests skepticism that any bid will close, though the stock may still function as a speculative event-driven lottery ticket. Higher bids and competitive processes can unlock materially better outcomes for targets, as seen in Soho House, Guess, and Dayforce where final prices exceeded earlier rumored or initial offers. Broadcasting stocks remain cyclical and relatively cheap because 2025 is a non-election year, but consolidation could improve industry economics and valuation multiples. Large buybacks are being used as a capital-allocation signal by companies with solid cash flows or improving fundamentals, especially in healthcare, insurance, grocery, and dialysis. Biotech insiders appear to be signaling confidence in Madrigal despite new competition, helped by strong commercial execution and EU approval for its MASH therapy. The Palo Alto/CyberArk deal and related founder departure suggest major strategic shifts in cybersecurity, particularly around identity security consolidation. Management resets, such as the return of Randolph Martin at Martin Transport, may indicate an attempt to restore discipline and improve performance in capital-intensive industries.

Data Points: Dallas News original Hearst offer: $14 per share - Initial bid in the contested Dallas News acquisition process Dallas News revised Hearst offer: $15 per share - Hearst increased its bid after competing pressure MNG latest Dallas News offer: $18.50 per share - New competing proposal for Dallas News Dallas News voting power: 55% of total voting power - Controlled by Robert Decherd through family/foundation Class B holdings Dallas News Class B voting ratio: 10 votes per share - Each Class B share has significantly more voting power than Class A MNG ownership in Dallas News: 9.9% - Stake held by MNG, near the poison-pill threshold Dallas News Class B ownership: 96.2% - Held by Robert Decherd’s family and foundation Dallas News current trading price: $14.97 - Stock traded below the existing $15 bid, implying skepticism Soho House deal value: $2.7 billion - Acquisition by NCR and its chairman/CEO Tyler Morse Soho House sale price: $9 per share - Cash consideration to shareholders Soho House premium: 17.8% - Premium to the last close Soho House closing timeline: Q4 of this year - Expected closing window Tegna deal value: $6.2 billion - All-cash acquisition by Nexstar Tegna sale price: $22 per share - Final announced transaction price Tegna pre-rumor price: $15.31 per share - Trading level before rumors surfaced Upside after rumor for Tegna: 9% - Remaining upside from rumor to definitive announcement Tegna deal spread: 4.36% - Spread at the time of discussion Tegna expected close: Second half of 2026 - Long-dated closing timeline affects arbitrage returns Guests deal value: $1.4 billion - Authentic Brands Group acquisition Guests sale price: $16.75 per share - Cash consideration to shareholders Guests prior offer: $13 per share - Initial WHP Global offer Guests pre-announcement trading price: about $13.70 - Price shortly before final acquisition announcement Mural Oncology market cap: $36 million - Company size at the time of sale Mural Oncology net cash: over $70 million - Cash on the balance sheet exceeded market cap Mural Oncology acquisition value: roughly $36 million - Zoma Royalty acquisition closing value Mural Oncology shareholder payout: about $2 per share in cash - Base consideration in the transaction Additional contingent cash: up to 20 cents per share - Potential additional payment for Mural shareholders Dayforce deal value: $12.3 billion - Acquisition by Thoma Bravo Dayforce sale price: $70 per share in cash - Final deal price Dayforce pre-rumor price: $52.88 per share - Trading price before rumor emerged Dayforce rumored price: $66.62 per share - Price after rumor but before final announcement Thoma Bravo public deal count: 35 deals - Public M&A transactions identified over the last 15 years Pediatrix Medical Group buyback: $250 million - Announcement representing a large portion of market cap Pediatrix buyback as market cap: 18% - Scale of repurchase authorization Old Republic buyback: $750 million - Insurance company repurchase plan Old Republic buyback as market cap: 8% - Size relative to equity value Old Republic shares retired: 18% over three years - Historical capital return pace Sprouts Farmers Market buyback: $1 billion - Announced share repurchase program Sprouts buyback as market cap: 7% - Scale of authorization Sprouts shares reduced: 16% over four years - Historical reduction in share count Sprouts 5-year stock performance: up about 505% - Strong multi-year share price appreciation DaVita buyback: $2 billion - Large authorization from dialysis services company DaVita buyback as market cap: 20% - Repurchase size relative to company value DaVita shares repurchased: 30% over four years - Historical cannibalization via buybacks Julian Baker Madrigal purchase: nearly $62 million - Chairman insider buying in Madrigal Pharmaceuticals Madrigal in John Paulson portfolio: 27.21% - Largest holding in Paulson’s latest 13F Madrigal quarterly revenue: $213 million - Second quarter of 2025 sales from Resmetirom/Resdifra commercialization Madrigal FDA milestone: 2024 first U.S. approval - First company approved to treat MASH in the U.S. Madrigal EU patient pool: over 370,000 addressable patients - Estimated European market opportunity Palo Alto Networks revenue: $9.22 billion - Last fiscal year ended June 2025 Palo Alto target revenue by 2030: $15 billion - Management long-term growth objective Palo Alto stock performance since CEO joined: up more than 500% - Performance since Nick Arora joined in June 2018 Martin Transport CEO tenure: 4 years and 4 months - Outgoing CEO Timothy Kohl’s tenure Martin Transport former CEO tenure: over 16 years - Randolph Martin’s previous tenure before returning Martin Transport market cap: $1 billion - Scale of the trucking company

Pivotal Quotes: "at this price, it essentially is a free lottery ticket, isn't it?" — Asif Suria: Commentary on Dallas News trading below the revised offer price "So, if they're acquiring companies at that scale, it makes the Toma Bravo 35 acquisitions all the more interesting and fascinating." — Luna Suria: Discussion of Thoma Bravo’s long record of public M&A activity "finally solve the identity security market" — Nick Aurora (paraphrased by hosts): Explanation of Palo Alto Networks’ rationale for acquiring CyberArk

Implications: The episode suggests event-driven investors should focus on control dynamics, regulatory risk, and deal rivalry, not just headline premiums. Buybacks and insider buying signal confidence in several fundamentally strong names, while big tech and biotech transactions highlight ongoing consolidation in software, security, and healthcare.